- Find
- Manage
- Resources
New Migraine Medicine
Drugmaker ProEthic Pharmaceuticals says that its new fast-acting migraine medicine continues to show promise in clinical trials. The drug, currently known as PRO-513, relieved migraine patients' pain, nausea, and sensitivity to light or sound better than a placebo in the latest studies.
Read moreMore information on "New Migraine Medicine"
From Our Experts
New Resource on Migraine Research Foundation's Website
The Migraine Research Foundation has added a great new resource for Migraine sufferers on our website - a new and improved list of doctors... Read more »
Migraine Medications: FDA Requires New Warnings on OTCs
We frequently discuss that it's important for our doctors to know about any over-the-counter (OTC) medications we take for Migraines and... Read more »
New Migraine and Headache Info on MMC, 8/11/10
Hello, everyone! Some weeks, we accumulate quite a bit of new Migraine and headache material on MyMigraineConnection. I realize some of... Read more »
Acupuncture for Migraine: Interpreting a New Study
Patients and health care professional alike diligently search for any treatments that are effective for Migraines. Researchers have been... Read more »
Migraine and Headache in the ER: New Report
Emergency department visits for headache disorders, Migraine in particular, is the topic of a report issued this month by the Agency for... Read more »
From Our Sources
Role of Complementary and Alternative Medicine for Treatment o...
Source: Medifocus Guidebook on: Migraine Headache
There are no studies to prove the efficacy or safety of most alternative therapies. It is important that migraineurs notify their health care... Read more »
New migraine med shows promise
A new migraine medicine called telcagepant was found safe and effective at treating migraines in a new comparative study with the migraine drug... Read more »
New migraine drugs may have new target
Scientists say they may have found a new "target" for future migraine medicines. New research published in the medical journal The Lancet suggest... Read more »
New Migraine Abortive Shows Promise without Vasoconstriction
Phase II study data on MK-0974, an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist showed:MK-0974 significantly... Read more »
Migraine Myths Debunked?
Tuesdays New York Times article Scientists Cast Misery of Migraine in a New Light highlights research that indicates that much of what we think... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
